125033646	125033646	CD	B-NP	O
|	|	NN	I-NP	O
MACMC	MACMC	NN	I-NP	O
|	|	NN	I-NP	O
66953321	66953321	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
374049	374049	CD	B-NP	O
|	|	CC	I-NP	O
9/18/2002	9/18/2002	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/12/2002	10/12/2002	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/12/2002	10/12/2002	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
GARVIN	GARVIN	NN	B-NP	B-protein
,	,	,	O	O
GARRETT	GARRETT	NN	B-NP	O
957-64-69-1	957-64-69-1	CD	I-NP	O
Ker	Ker	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
9/14/02	9/14/02	CD	B-NP	O
AT	AT	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
TARLTON	TARLTON	NNP	B-NP	O
,	,	,	O	O
TOBY	TOBY	NNP	B-NP	O
ALEX	ALEX	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DISPOSITION	DISPOSITION	NNP	I-NP	O
:	:	:	O	O
Home	Home	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
BABY	BABY	NN	B-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NNP	I-NP	O
ACID	ACID	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CHILDREN	CHILDREN	NNP	I-NP	O
'S	'S	POS	B-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	O
81	81	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
ALBUTEROL	ALBUTEROL	NN	I-NP	O
NEBULIZER	NEBULIZER	NN	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NN	I-NP	O
NEB	NEB	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
LASIX	LASIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FUROSEMIDE	FUROSEMIDE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
60	60	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
6/22	6/22	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/14/02	9/14/02	CD	B-NP	O
by	by	IN	B-PP	O
IWANICKI	IWANICKI	NNP	B-NP	O
,	,	,	O	O
JOSUE	JOSUE	NNP	B-NP	O
MASON	MASON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DILTIAZEM	DILTIAZEM	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
monitored	monitor	VBN	I-VP	O
NPH	NPH	NNP	B-NP	O
HUMULIN	HUMULIN	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
60	60	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
BID	BID	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
REGULAR	REGULAR	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
30	30	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
BID	BID	NNP	I-NP	O
RANITIDINE	RANITIDINE	NN	I-NP	B-protein
HCL	HCL	NN	I-NP	I-protein
150	150	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	O
K-DUR	K-DUR	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
KCL	KCL	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
X	X	SYM	I-NP	O
1	1	CD	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
HCH	HCH	NN	B-NP	O
Potassium	Potassium	NN	I-NP	O
Chloride	Chloride	NN	I-NP	O
Policy	Policy	NN	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
LOSARTAN	LOSARTAN	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
LIPITOR	LIPITOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
30	30	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/14/02	9/14/02	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
DEFINITE	DEFINITE	NN	B-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
HMG	HMG	NN	B-NP	B-protein
CoA	CoA	NN	I-NP	I-protein
REDUCTASE	REDUCTASE	NN	I-NP	I-protein
INHIBITORS	INHIBITORS	VBZ	B-VP	O
Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
drug	drug	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpt	outpt	NN	I-NP	O
.	.	.	O	O

CARDIZEM	CARDIZEM	NN	B-NP	O
CD	CD	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
DILTIAZEM	DILTIAZEM	NN	I-NP	O
CD	CD	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
300	300	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/14/02	9/14/02	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
FUROSEMIDE	FUROSEMIDE	NNP	B-NP	O
&	&	CC	I-NP	O
DILTIAZEM	DILTIAZEM	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-ADVP	O
med	me	VBN	B-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpt	outpt	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
RETURN	RETURN	NNP	I-NP	O
TO	TO	NNP	I-NP	O
WORK	WORK	NNP	I-NP	O
:	:	:	O	O
IN	IN	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
DAYS	DAYS	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Primary	Primary	JJ	B-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
-	-	HYPH	B-NP	O
Please	Please	NN	I-NP	O
call	call	NN	I-NP	O
for	for	IN	B-PP	O
appt	appt	NN	B-NP	O
.	.	.	O	O

,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
Latex	Latex	NNP	B-NP	O
,	,	,	O	O
Lovastatin	Lovastatin	NNP	B-NP	O
,	,	,	O	O
Enalapril	Enalapril	NNP	B-NP	O
maleate	maleate	NN	I-NP	O
,	,	,	O	O
Codeine	Codeine	NNP	B-NP	O
,	,	,	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
Pravachol	Pravachol	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
pravastatin	pravastatin	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Levamisole	Levamisole	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
levamisole	levamisole	NN	I-NP	O
hcl	hcl	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
dyspnea	dyspnea	NN	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
diabetes	diabete	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CHF	CHF	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
HTN	HTN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
50	50	CD	B-NP	O
y.o.	y.o.	NN	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
medical	medical	JJ	I-NP	O
problems	problem	NNS	I-NP	O
including	include	VBG	B-PP	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
IDDM	IDDM	NN	B-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
sleep	sleep	NN	B-NP	O
apnea	apnea	NN	I-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
SOB	SOB	NN	B-NP	B-protein
x	x	SYM	B-NP	O
1	1	CD	I-NP	O
month	month	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
following	follow	VBG	B-PP	O
a	a	DT	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
about	about	IN	B-NP	O
1	1	CD	I-NP	O
year	year	NN	I-NP	O
ago	ago	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
felt	feel	VBN	I-VP	O
progressively	progressively	RB	B-ADVP	O
short	short	RB	I-ADVP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
month	month	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
have	have	VBP	B-VP	O
become	become	VBN	I-VP	O
incerasingly	incerasingly	RB	B-ADJP	O
bothersome	bothersome	JJ	I-ADJP	O
,	,	,	O	O
interfering	interfere	VBG	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-PP	O
talk	talk	NN	B-NP	O
,	,	,	O	O
walk	walk	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
exert	exert	VB	B-VP	O
herself	herself	PRP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
fever/chills	fever/chill	NNS	B-NP	O
/	/	SYM	O	O
chest	chest	NN	B-NP	O
pain/palpitations/PND	pain/palpitations/PND	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
does	do	VBZ	B-VP	O
report	report	VB	I-VP	O
4	4	CD	B-NP	O
pillow	pillow	NN	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
increased	increase	VBD	B-VP	O
from	from	IN	B-PP	O
2	2	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
nocturia	nocturia	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
pulmonologist	pulmonologist	NN	I-NP	B-protein
5/6	5/6	CD	I-NP	I-protein
who	who	WP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	DT	O	O
her	her	PRP$	B-NP	O
lung	lung	NN	I-NP	O
disease	disease	NN	I-NP	O
was	be	VBD	B-VP	O
most	most	RBS	B-ADJP	O
consistent	consistent	JJ	I-ADJP	O
with	with	IN	B-PP	O
restrictive	restrictive	JJ	B-NP	O
lung	lung	NN	I-NP	O
disease	disease	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
obesity	obesity	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
allergist	allergist	NN	I-NP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
PTA	PTA	NN	I-NP	B-protein
,	,	,	O	O
who	who	WP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
CXR	CXR	NN	I-NP	B-protein
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
and	and	CC	O	O
increased	increase	VBD	B-VP	O
her	her	PRP$	B-NP	O
lasix	lasix	NN	I-NP	O
to	to	TO	B-PP	O
100	100	CD	B-NP	O
qdx	qdx	NN	I-NP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
decreased	decrease	VBN	I-NP	O
O2	O2	NN	I-NP	O
sat	sat	NN	I-NP	O
;	;	:	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
to	to	TO	B-PP	O
TSGH	TSGH	NN	B-NP	B-protein
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
many	many	JJ	B-NP	O
allergies	allergy	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
latex	latex	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
1.5	1.5	CD	I-NP	O
ppd	ppd	NN	I-NP	O
smoker	smoker	NN	I-NP	O
x	x	SYM	O	O
30	30	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
quit	quit	VB	B-VP	O
one	one	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
half	half	NN	I-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
recently	recently	RB	I-VP	O
started	start	VBN	I-VP	O
a	a	DT	B-NP	O
weight	weight	NN	I-NP	O
loss	loss	NN	I-NP	O
program	program	NN	I-NP	O
,	,	,	O	O
losing	lose	VBG	B-VP	O
22	22	CD	B-NP	O
pounds	pound	NNS	I-NP	O
in	in	IN	B-PP	O
3	3	CD	B-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
solumedrol	solumedrol	NN	B-NP	O
,	,	,	O	O
nebs	neb	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
ativan	ativan	NN	B-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
relief	relief	NN	I-NP	O
.	.	.	O	O

Pertinent	Pertinent	JJ	B-NP	O
exam	exam	NN	I-NP	O
findings	finding	NNS	I-NP	O
:	:	:	O	O
markedly	markedly	RB	B-NP	O
obese	obese	JJ	I-NP	O
,	,	,	I-NP	O
labored	labored	JJ	I-NP	O
breathing	breathing	NN	I-NP	O
at	at	IN	B-PP	O
times	time	NNS	B-NP	O
,	,	,	O	O
but	but	CC	O	O
speaking	speak	VBG	B-VP	O
in	in	IN	B-PP	O
full	full	JJ	B-NP	O
sentences	sentence	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
JVD	JVD	NN	I-NP	B-protein
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
:	:	:	O	O
rare	rare	JJ	B-NP	O
wheezes	wheeze	NNS	I-NP	O
,	,	,	O	O
few	few	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
at	at	IN	B-PP	O
bases	base	NNS	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
consolidation	consolidation	NN	B-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
distant	distant	JJ	B-ADJP	O
,	,	,	O	O
RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
S1	S1	NN	B-NP	O
S2	S2	NN	I-NP	O
Abd	Abd	NN	I-NP	O
:	:	:	O	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
obese	obese	JJ	I-NP	O
Ext	Ext	NNP	I-NP	O
:	:	:	O	O
trace	trace	NN	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
WWP	WWP	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
calf	calf	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

A/P	A/P	NN	B-NP	O
:	:	:	O	O
Pulm	Pulm	NN	B-NP	O
:	:	:	O	O
Likely	Likely	RB	B-NP	O
restrictive	restrictive	JJ	I-NP	O
component	component	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
obesity	obesity	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
deconditioning	deconditioning	NN	B-NP	O
,	,	,	O	O
likely	likely	RB	B-NP	O
anxiety	anxiety	NN	I-NP	O
component	component	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
possible	possible	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-VP	O
sleep	sleep	VB	I-VP	O
apnea	apnea	NN	B-NP	O
,	,	,	O	O
smoking	smoking	NN	B-NP	O
hx	hx	NN	I-NP	O
.	.	.	O	O

Subjectively	Subjectively	RB	B-ADVP	O
,	,	,	O	O
acute	acute	JJ	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
of	of	IN	B-PP	O
sx	sx	NN	B-NP	O
may	may	MD	B-VP	O
also	also	RB	I-VP	O
be	be	VB	I-VP	O
related	relate	VBN	B-ADJP	O
to	to	TO	B-PP	O
heat/humidity	heat/humidity	NN	B-NP	O
.	.	.	O	O

Nebs	Neb	NNS	B-NP	O
for	for	IN	B-PP	O
comfort	comfort	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
primary	primary	JJ	B-NP	O
goal	goal	NN	I-NP	O
is	be	VBZ	B-VP	O
for	for	IN	B-SBAR	O
increased	increase	VBN	B-NP	O
cardiopulmonary	cardiopulmonary	JJ	I-NP	O
fitness	fitness	NN	I-NP	O
,	,	,	O	O
weight	weight	NN	B-NP	O
loss	loss	NN	I-NP	O
.	.	.	O	O

CPAP	CPAP	NN	B-NP	B-protein
for	for	IN	B-PP	O
sleep	sleep	JJ	B-NP	O
apnea	apnea	NN	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

Outpatient	Outpatient	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
rehab	rehab	NN	I-NP	O
.	.	.	O	O

O2	O2	NN	B-NP	O
sat	sit	VBD	B-VP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	O
with	with	IN	B-PP	O
ambulation	ambulation	NN	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
d/c	d/c	NN	B-NP	O
.	.	.	O	O

Symptoms	Symptom	NNS	B-NP	O
improved	improve	VBD	B-VP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
continue	continue	VB	B-VP	O
cardiac	cardiac	JJ	B-NP	O
meds	med	NNS	I-NP	O
,	,	,	O	O
lipid	lipid	NN	B-NP	O
lowering	lower	VBG	B-VP	O
agents	agent	NNS	B-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
infectious	infectious	JJ	I-NP	O
etiology/sx	etiology/sx	NN	I-NP	O
Endo	Endo	NNP	I-NP	O
:	:	:	O	O
Type	Type	NN	B-NP	O
2	2	CD	B-NP	O
DM	DM	NN	I-NP	O
-	-	HYPH	B-NP	O
continue	continue	JJ	I-NP	O
current	current	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

Sent	Sent	JJ	B-NP	O
HgbA1C	HgbA1C	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
increasing	increase	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
headache	headache	NN	B-NP	O
,	,	,	O	O
fever	fever	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
other	other	JJ	B-NP	O
worrisome	worrisome	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-INTJ	O
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
or	or	CC	O	O
return	return	VB	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
get	get	VB	I-VP	O
your	your	PRP$	B-NP	O
CPAP	CPAP	NN	I-NP	B-protein
machine	machine	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
d/c	d/c	NN	B-NP	O
,	,	,	O	O
please	please	VB	B-INTJ	O
obtain	obtain	VB	B-VP	O
one	one	CD	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
SKIBOSH	SKIBOSH	NN	B-NP	O
,	,	,	O	O
MATHEW	MATHEW	NNP	B-NP	O
CHANCE	CHANCE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
TW20	TW20	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
9/14/02	9/14/02	CD	I-NP	O
@	@	HYPH	B-NP	O
12	12	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

